There is little time left for Avenue Therapeutics Inc (ATXI) to reach its 1-year target estimate. How soon will it surpass it?
Avenue Therapeutics Inc (NASDAQ:ATXI) shares traded -6.99% lower at $0.17 on Wall Street last session. In accordance with the data, 1 analysts cover Avenue Therapeutics Inc (NASDAQ:ATXI). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $32.00 and a low of $32.00, […]